GB0604781D0 - Use of substituted phenyl-piperazine compounds for the treatment of food related disorders - Google Patents
Use of substituted phenyl-piperazine compounds for the treatment of food related disordersInfo
- Publication number
- GB0604781D0 GB0604781D0 GBGB0604781.5A GB0604781A GB0604781D0 GB 0604781 D0 GB0604781 D0 GB 0604781D0 GB 0604781 A GB0604781 A GB 0604781A GB 0604781 D0 GB0604781 D0 GB 0604781D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- substituted phenyl
- related disorders
- piperazine compounds
- food related
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical class C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0604781A GB2435828A (en) | 2006-03-09 | 2006-03-09 | Use of substituted phenyl-piperazine compounds for treatment of food related disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0604781A GB2435828A (en) | 2006-03-09 | 2006-03-09 | Use of substituted phenyl-piperazine compounds for treatment of food related disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0604781D0 true GB0604781D0 (en) | 2006-04-19 |
GB2435828A GB2435828A (en) | 2007-09-12 |
Family
ID=36241305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0604781A Withdrawn GB2435828A (en) | 2006-03-09 | 2006-03-09 | Use of substituted phenyl-piperazine compounds for treatment of food related disorders |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2435828A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111417637A (en) * | 2017-12-07 | 2020-07-14 | 鲁南制药集团股份有限公司 | Anti-pain compounds and process for preparing same |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013134562A1 (en) | 2012-03-09 | 2013-09-12 | Inception 2, Inc. | Triazolone compounds and uses thereof |
WO2014099503A1 (en) | 2012-12-20 | 2014-06-26 | Inception 2, Inc. | Triazolone compounds and uses thereof |
CN105579440A (en) | 2013-09-06 | 2016-05-11 | 因森普深2公司 | Triazolone compounds and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003299791A1 (en) * | 2002-12-20 | 2004-07-22 | Bayer Pharmaceuticals Corporation | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
US20060014757A1 (en) * | 2004-07-14 | 2006-01-19 | Boehringer Ingelheim Pharmaceuticals | Method for the treatment of anorexia nervosa |
-
2006
- 2006-03-09 GB GB0604781A patent/GB2435828A/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111417637A (en) * | 2017-12-07 | 2020-07-14 | 鲁南制药集团股份有限公司 | Anti-pain compounds and process for preparing same |
CN111417637B (en) * | 2017-12-07 | 2022-09-13 | 山东新时代药业有限公司 | Anti-pain compounds and process for preparing same |
Also Published As
Publication number | Publication date |
---|---|
GB2435828A (en) | 2007-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1976377A4 (en) | Compounds for the treatment of metabolic disorders | |
EP1983972A4 (en) | Compounds for the treatment of metabolic disorders | |
IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
ZA200808963B (en) | Compounds for the treatment of metabolic disorders | |
ZA200806074B (en) | Compounds for the treatment of inflammatory disorders | |
IL190920A0 (en) | Compounds for the treatment of metabolic disorders | |
IL194076A0 (en) | Imidazolothiazole compounds for the treatment of disease | |
IL185016A0 (en) | Compounds for the treatment of proliferative disorders | |
HK1152939A1 (en) | Carboxamide compounds for the treatment of metabolic disorders | |
EP2139475A4 (en) | The use of pde7 inhibitors for the treatment of movement disorders | |
ZA200805645B (en) | Compounds for the treatment of metabolic disorders | |
ZA200806455B (en) | Use of 2-imidazoles for the treatment of CNS disorders | |
GB0604780D0 (en) | Use of substituted piperazine compounds for the treatment of food related disorders | |
IL192877A0 (en) | Use of 2-imidazoles for the treatment of cns disorders | |
IL192851A0 (en) | Compounds for the treatment of metabolic disorders | |
GB0604781D0 (en) | Use of substituted phenyl-piperazine compounds for the treatment of food related disorders | |
IL195392A0 (en) | Compounds for the treatment of metabolic disorders | |
PL1982178T3 (en) | Methods for the treatment of affective disorders | |
GB0604782D0 (en) | Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders | |
HK1158626A1 (en) | Sulfonamide compounds for the treatment of respiratory disorders | |
EP2240024A4 (en) | Compounds for the treatment of metabolic disorders | |
GB0604772D0 (en) | Use of substituted amine compounds for the treatment of food related disorders | |
GB0604783D0 (en) | Use of substituted oxime compounds for the treatment of food related disorders | |
IL192982A0 (en) | Compounds for the treatment of metabolic disorders | |
GB0604778D0 (en) | Use of substituted amine compouds fo the treatment of food related disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |